Clinical trial Recruiting at 1 site Observational Ages 20 to 60

Understanding how 5-HT7 affects sleep apnea caused by arousal issues

Official title: Unveiling the Neural Mechanisms of 5-HT7 in Sleep Apnea Induced by Arousal Dysregulation

Run by Beijing Tsinghua Chang Gung Hospital · NCT06608888 · Data updated 2026-11-12

This study is trying to see how a specific brain receptor affects sleep apnea caused by waking up too easily, by comparing healthy people, simple snorers, and those with sleep apnea.

Quick facts

Study typeObservational
Ages20 Years to 60 Years
SexAll
Enrollment140 (estimated)
SponsorBeijing Tsinghua Chang Gung Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 30, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedSeptember 26, 2024
Trial IDNCT06608888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 20 to 60 with confirmed obstructive sleep apnea, simple snoring, or no sleep-related symptoms.

Probably not a fit

Patients with severe pulmonary, neurological, or cardiovascular complications, or those with specific sleep disorders unrelated to OSA may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the role of the 5-HT7 receptor in obstructive sleep apnea (OSA) by comparing arousal thresholds and brain network structures among healthy individuals, simple snorers, and OSA patients. It consists of a cross-sectional analysis to assess differences in brain connectivity and arousal regulation, followed by a longitudinal follow-up of OSA patients undergoing CPAP treatment to observe changes in brain function and structure. The goal is to uncover the neural mechanisms linking arousal dysregulation to OSA pathogenesis.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment options for patients with obstructive sleep apnea.

How similar studies have gone: While the approach of examining the 5-HT7 receptor in relation to sleep apnea is relatively novel, similar studies have shown promise in understanding the neural mechanisms of sleep disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

OSA Patients:

* Age between 20 and 60 years.
* Symptoms of sleep snoring and daytime sleepiness.
* Confirmed diagnosis of OSA following overnight sleep monitoring.

Simple Snorers:

* Age between 20 and 60 years.
* Symptoms of sleep snoring.
* Overnight sleep monitoring indicates not meeting the OSA diagnosis.

Healthy Controls:

* Age between 20 and 60 years.
* No symptoms of sleep snoring.
* Overnight sleep monitoring rules out the diagnosis of OSA.

Exclusion Criteria:

* Presence of severe pulmonary, neurological, or cardiovascular complications.
* History of long-term non-invasive positive pressure ventilation treatment (more than 3 months) or upper airway surgery.
* Sleep-disordered breathing due to special etiologies such as hypothyroidism, acromegaly, vocal cord paralysis, etc.
* Presence of severe mental illness, long-term alcohol abuse, or a history of prolonged use of sedative-hypnotic drugs.
* Central sleep apnea predominant sleep disorders due to various causes.
* Severe craniofacial deformities, myasthenia gravis, or other known myopathic histories.
* Patients with peripheral neuropathy caused by diabetes, autoimmune diseases, etc.
* Patients with comorbid insomnia, anxiety, depression, or other types of sleep disorders.

Where it's running

  • No. 168 Litang Road, Changping District
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Jingying Ye — BeijingTsinghua Changgung Hospital,Tsinghua University
  • Study coordinator: Yingqian Zhou
  • Email: yingqianzhou9112@126.com
  • Phone: 010-56119472

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.